Intervacc
About:
Intervacc is a biotechnology company that develops vaccines based on recombinant proteins for animal health.
Website: http://www.intervacc.se
Twitter/X: https://twitter.com/intervacc_se
Top Investors: Vinnova, Knutsson Holdings AB
Description:
Intervacc develops vaccines based on recombinant proteins for use in animal health care. They focus on diagnostics in the animal health market and provide bacteriological and mycological analyzes.
Total Funding Amount:
30M SEK
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Hägersten, Stockholms Lan, Sweden
Founded Date:
2001-01-01
Contact Email:
info(AT)intervacc.se
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-08-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai